New Whitepaper: Origination in the Age of AI–How signal-driven infrastructure is replacing broker-dependent deal flow.Read now↗

Transaction Intelligence
Transactions
Closed & announced M&A across every sector and state.
Sectors
Browse transactions by industry vertical.
States
Browse transactions by U.S. state.
Buyers
Browse transactions by acquiring company.
On-marketComing soon
Businesses actively listed for sale.
PE Firms M&A Firms Commercial Lenders Investment Banks
Deal Origination
End-to-end outreach infrastructure that sources proprietary deal flow.
Data & Research
TAM mapping, data enrichment, custom scraping, and automated research.
AI Implementation
How Tentt deploys AI across your deal origination stack.
Resources
Playbooks
Channel-specific outreach playbooks for deal origination.
All research
Comparison posts, methodology, and analysis from the Tentt team.
Reports
Monthly market reports on M&A and private equity activity.
Tools
Free calculators for M&A, lending, and deal analysis.
Whitepaper↗
Origination in the Age of AI.
About
Book an intro call

Shionogi — Acquisitions & M&A Deals

2 deals

Tracking 2 M&A deals by Shionogi.

Shionogi completes acquisition of rights to ALS drug Radicava - ALS News Today

HealthcareFloridaDivestiture

Shionogi→Radicava rights

Apr 8, 2026

Shionogi: $2.5 Billion Acquisition Of RADICAVA Establishes Rare Disease Platform - Pulse 2.0

HealthcarePlatform

Shionogi→RADICAVA (edaravone) global rights from Tanabe Pharma

Apr 3, 2026